Large-scale testing (Phase 3)Study completedNCT00376272
What this trial is testing
GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence
Who this might be right for
Atrial Fibrillation
Gruppo di Ricerca GISSI 1,442